According to a health ministry document and an official, the German government struck two preliminary deals with BioNTech and CureVac last summer to secure 50 million doses of their COVID-19 vaccines, as reported in the National Post on Friday.
The deals, which were not announced when they were signed, are deemed controversial because EU governments had agreed not to negotiate bilateral supply agreements with vaccine makers.
The ministry official said Germany signed a memorandum of understanding with CureVac on August 31 for the supply of 20 million doses of its vaccine under development.
The official said the country also signed a similar preliminary deal on September 8 with BioNTech for 30 million doses of the vaccine it co-developed with Pfizer.
Deliveries to Germany under both deals would start only after EU countries were supplied under EU deals, according to the official.
This included an EU contract announced earlier on Friday for 300 million additional doses, a spokesman for the health ministry added.
To read more NewsPoints articles, click here.